Financials Quipt Home Medical Corp.

Equities

QIPT

CA74880P1045

Healthcare Facilities & Services

Market Closed - Toronto S.E. 15:59:59 2024-05-09 EDT 5-day change 1st Jan Change
5.48 CAD -2.14% Intraday chart for Quipt Home Medical Corp. +0.18% -18.81%

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 71 146.5 263.2 192.2 292.6 238.4 - -
Enterprise Value (EV) 1 71 124.8 263.2 192.2 292.6 238.4 238.4 238.4
P/E ratio -9.44 x -18.7 x -31.1 x 32.2 x -74.1 x 157 x 26.6 x 8.82 x
Yield - - - - - - - -
Capitalization / Revenue 0.88 x 1.5 x 2.02 x 1.01 x 0.98 x 0.66 x 0.61 x 0.5 x
EV / Revenue 0.88 x 1.5 x 2.02 x 1.01 x 0.98 x 0.66 x 0.61 x 0.5 x
EV / EBITDA 4.8 x 7.04 x 9.69 x 4.84 x 4.31 x 2.86 x 2.61 x 2.24 x
EV / FCF - 8.37 x 15.2 x 8.23 x 6.47 x 3.92 x - -
FCF Yield - 11.9% 6.59% 12.1% 15.5% 25.5% - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 20,882 27,961 33,236 33,720 42,102 42,572 - -
Reference price 2 3.400 5.240 7.920 5.700 6.950 5.480 5.480 5.480
Announcement Date 20-01-28 21-02-01 22-01-27 22-12-21 23-12-18 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 80.97 97.76 130.1 190.5 297.3 361.5 392.3 473.3
EBITDA 1 14.8 20.8 27.17 39.74 67.83 83.46 91.18 106.5
EBIT 1 0.832 0.885 4.558 8.359 13.94 12.61 18.57 59.03
Operating Margin 1.03% 0.91% 3.5% 4.39% 4.69% 3.49% 4.73% 12.47%
Earnings before Tax (EBT) 1 -8.872 -5.425 -11.86 3.013 -3.589 2.318 9.651 48.77
Net income 1 -7.386 -6.755 -7.85 6.592 -3.732 0.6274 9.174 24.3
Net margin -9.12% -6.91% -6.03% 3.46% -1.26% 0.17% 2.34% 5.13%
EPS 2 -0.3600 -0.2800 -0.2543 0.1771 -0.0938 0.0349 0.2060 0.6215
Free Cash Flow 1 - 17.51 17.35 23.35 45.24 60.79 - -
FCF margin - 17.91% 13.33% 12.25% 15.22% 16.82% - -
FCF Conversion (EBITDA) - 84.17% 63.85% 58.74% 66.7% 72.83% - -
FCF Conversion (Net income) - - - 354.16% - 9,688.1% - -
Dividend per Share - - - - - - - -
Announcement Date 20-01-28 21-02-01 22-01-27 22-12-21 23-12-18 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 37.02 37.61 43.37 47.33 54.61 54.49 78.45 81.18 83.82 88.6 88.57 90.37 92.51 95.09 94.08
EBITDA 1 6.956 7.65 9.097 9.93 11.44 12.01 17.68 18.71 19.71 20.79 20.69 21.28 21.72 22.13 22.26
EBIT 1 0.0941 1.264 2.05 3.012 1.628 2.94 4.747 2.962 3.486 4.058 2.91 3.287 3.829 4.16 4.296
Operating Margin 0.25% 3.36% 4.73% 6.36% 2.98% 5.4% 6.05% 3.65% 4.16% 4.58% 3.29% 3.64% 4.14% 4.38% 4.57%
Earnings before Tax (EBT) 1 -3.447 -2.526 6.701 0.4102 -0.8064 0.8785 -1.011 -1.827 -1.661 -0.4961 0.4566 0.8855 1.438 1.864 2.134
Net income 1 -1.903 -2.715 6.501 0.2103 2.411 0.4339 -1.011 -1.346 -1.778 -0.7943 0.435 0.8355 1.354 1.864 2.134
Net margin -5.14% -7.22% 14.99% 0.44% 4.41% 0.8% -1.29% -1.66% -2.12% -0.9% 0.49% 0.92% 1.46% 1.96% 2.27%
EPS 2 -0.0509 -0.0764 0.1807 - 0.0681 0.0134 -0.0270 -0.0404 -0.0402 -0.0136 0.009000 0.0246 0.0380 0.0475 0.0545
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 22-01-27 22-02-14 22-05-16 22-08-15 22-12-21 23-02-13 23-05-15 23-08-14 23-12-18 24-02-14 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - 21.7 - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - 17.5 17.3 23.3 45.2 60.8 - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - -6.84% - - - - -
Assets 1 - - 114.8 - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share 0.5400 - - - - - - -
Capex 1.8 0.12 6.42 - - - - -
Capex / Sales 2.23% 0.13% 4.93% - - - - -
Announcement Date 20-01-28 21-02-01 22-01-27 22-12-21 23-12-18 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
5.6 CAD
Average target price
13.42 CAD
Spread / Average Target
+139.58%
Consensus
  1. Stock Market
  2. Equities
  3. QIPT Stock
  4. Financials Quipt Home Medical Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW